Sanofi tiptoes toward selling some older products

Carly Helfand

Back in April, was said to be considering spring cleaning, weighing a sale of to make room for the bolt-on deals CEO Chris Viehbacher wants to make. Sanofi appears to be heading down that path; the pharma giant is in the "very early stages" of weighing a sale of its meds, Reuters sources say.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS